Elocalcitol, a vitamin D3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility.
IDrugs : the investigational drugs journal • Vol. 12, Issue 6 • 2009
Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
Steroids • Vol. 71, Issue 4 • 2006
Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).
Journal of endocrinological investigation • Vol. 29, Issue 7 • 2006
Human bladder as a novel target for vitamin D receptor ligands.
The Journal of clinical endocrinology and metabolism • Vol. 90, Issue 2 • 2005
